BofA lowered the firm’s price target on Rocket Lab to $10 from $12 and keeps a Buy rating on the shares. The firm states that it retains its view of the stock as the strongest pure-play space name within its coverage despite the recent Electron anomaly as the Space Systems business continues to perform strongly with the ramp up of the $143M MDA Globalstar contract, for which first delivery is slated to occur in Q1 of 2024. BofA further notes that demand for the Launch platform remains robust, with 2024 completely booked and coming in above the prior BofA estimates on Electron launches. The firm adds however that it is reassessing its discount rate post-mission failure to reflect Rocket Lab’s risk profile more accurately, raising its discount rate to 14.5% vs. prior 13.5%.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on RKLB:
